Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

There comes a point in the life of every brand when exclusivity will be lost and generics will begin to compete for market share. However this is not the end of the brand’s lifecycle and many ...

Global X Robotics & Artificial Intelligence is diversified across capital goods, hardware, and healthcare, reducing valuation ...

The VIX is known as the Fear Gauge because it tracks how much investors are paying for protection against a market decline.

As employers grapple with including GLP-1s in their benefits packages, they face a complex decision that boils down to two ...

Genpharmasec Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 172.21 Crore ... the company has a total of 55.37 Crore shares outstanding.Generic Pharmasec Share ...

However, this relies on there being competition in the market. Recently, the media has highlighted a number of instances where, in the absence of competition, the price of an old generic drug has ...

Apparently unbeknownst to my Republican friends, the effort to cut ‘government waste’ has a long, bipartisan, history in the ...

The IPO page of Generic ... Value, Price band, Issue Size, Issue Type, and Listing Date's Open Price, High Price, Low Price, Close price and Volume. It also captures the Holding Period Returns and ...

These companies have made generations of investors wealthy, and you can probably pass the stocks on to your children someday.